17Cicada

17Cicada

Using engineered bacteria to convert CO2 & waste into low carbon chemicals and fuels.

Company Details

Location
Cambridge, United Kingdom
Founded
2021
Employees
4-10
Funding
USD $1M-$5M

Management Team

Athan Fox avatar

Athan Fox

CEO

Mr Andrew Rogan avatar

Mr Andrew Rogan

CCO

Dr Samantha Bryan avatar

Dr Samantha Bryan

CTO

    Dr Peter Knight avatar

    Dr Peter Knight

    COO

      Learn more

      About 17Cicada

      The problem we're solving:

      Incumbent plastics, derived from crude oil, account for 4% of all greenhouse gas emissions (i.e. twice the footprint of aviation) and produce significant waste at end of life. Fortunately, bioplastics produced from furan di-carboxylic acid (FDCA) reduce emissions by at least 60% and minimise waste. However, the adoption of FDCA bioplastics has been hindered by high costs: 50% of the cost of producing FDCA is due to hydroxymethyl furfural, HMF – an intermediate material used to manufacture FDCA.

      Our solution:

      Our pioneering, patent-pending technology, overcomes the formidable challenge and cost of HMF synthesis. We use bacteria and a novel metabolic pathway to convert waste feedstocks into FDCA. Our bacteria can use multiple types of feedstocks and turn these into HMF, which is further converted by the bacteria into FDCA. This synthetic biology (SynBio) process is a world first. By engineering bacteria, we can also produce hydrogen – we envisage using this hydrogen to power our future operations.

      Our differentiator:

      Our process is first-of-its-kind. Unlike competitors, we go from feedstock directly to FDCA (i.e. without isolating/handling intermediate products). We do not use catalysts, and do not produce “humins” – oily by-products which are difficult to remove. Also, unlike competitors, we do not rely on sugar – our feedstocks are lignocellulose, chitin and some types of waste plastic (again, this is a world first). As for our hydrogen, it is truly carbon-negative (i.e. made by consuming carbon dioxide).

      Our biggest achievement:

      We have won grant-funding of more than £1 million GBP to date. On the hydrogen project, we have successfully produced hydrogen using photosynthetic bacteria with carbon dioxide as feedstock – our biggest achievement is producing the hydrogen continuously in the presence of light (a world first). On the FDCA project, we have successfully produced 1 gram per Litre of FDCA – a significant quantity or concentration when it comes to wild strains of bacteria.
      Disclaimer:
      Information for this page was sourced directly from the startups or found in publicly available databases. The data has been collected until the end of the programme's year (eg: A 2020 programme has data updated until December 2020) except for where explicitly said so. The data on co-founders is collected upon startup registration and is not further updated. Funds raised is comprised of direct investments (including crowdfunding), funds, and grants. Opinions, conclusions and views expressed in the startup page are solely personal to the author (startup), unless otherwise clearly stated.